Mar 01, 2022 / 10:00PM GMT
Operator
Good afternoon, everyone. Thank you for standing by. Welcome to the CytomX Therapeutics Fourth Quarter and Full Year 2021 Financial Results Call. Please be advised that today's call is being recorded.
I would now like to hand the call over to your host today, Chau Cheng, CytomX's Vice President, Investor Relations and Corporate Communications. Please go ahead.
Chau Cheng - CytomX Therapeutics, Inc. - VP of IR & Corporate Communications
Thank you, Michelle. Good afternoon, and thank you for joining us. With me today are Dr. Sean McCarthy, CytomX' Chief Executive Officer and Chairman; Dr. Amy Peterson, President and Chief Operating Officer; and Chris Ogden, Vice President, Finance and Accounting.
Earlier today, we issued a press release that includes a summary of our fourth quarter and full year 2021 financial results and highlights the important progress we made during the year. We encourage everyone to read today's press release and the associated materials, which have been filed with the SEC. Additionally, the press release and recording
Q4 2021 CytomX Therapeutics Inc Earnings Call Transcript
Mar 02, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers